We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novartis Ag Basel Namen Akt (PK) | USOTC:NVSEF | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 105.17 | 104.29 | 118.12 | 20 | 21:20:00 |
|
|
Novartis AG Postfach 4002 Basel Switzerland |
January 27, 2015
US Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re: Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Novartis AG has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2014, which was filed with the Securities and Exchange Commission on January 27, 2015.
|
Respectfully submitted, |
|
|
|
|
|
|
|
Novartis AG |
|
|
|
|
|
|
|
|
|
|
|
/s/ FELIX R. EHRAT |
|
/s/ HARRY KIRSCH |
|
Felix R. Ehrat |
|
Harry Kirsch |
|
General Counsel |
|
Chief Financial Officer |
|
Novartis Group |
|
Novartis Group |
1 Year Novartis Ag Basel Namen ... (PK) Chart |
1 Month Novartis Ag Basel Namen ... (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
